Babies’ Genomes Identify Risks Overlooked by Newborn Screens
Babies’ Genomes Identify Risks Overlooked by Newborn Screens
A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.
Babies’ Genomes Identify Risks Overlooked by Newborn Screens
Babies’ Genomes Identify Risks Overlooked by Newborn Screens

A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.

A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.

BabySeq
Q&A: Sequencing Newborns
Q&A: Sequencing Newborns
Tracy Vence | Oct 21, 2016
Members of the BabySeq Project discuss trial enrollment, preliminary findings.